blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2262512

EP2262512 - COMPOSITIONS AND METHODS FOR USING STROMAL CELLS TO ENHANCE TREATMENT OF CENTRAL NERVOUS SYSTEM INJURIES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  06.02.2015
Database last updated on 15.07.2024
Most recent event   Tooltip06.02.2015Application deemed to be withdrawnpublished on 11.03.2015  [2015/11]
Applicant(s)For all designated states
Henry Ford Health System
1 Ford Place
Detroit, MI 48202 / US
[2010/51]
Inventor(s)01 / CHOPP, Michael
28415 Brooks Lane
Southfield, MI 48034 / US
 [2010/51]
Representative(s)Viering, Jentschura & Partner mbB Patent- und Rechtsanwälte
Hamborner Straße 53
40472 Düsseldorf / DE
[N/P]
Former [2012/33]Viering, Jentschura & Partner
Kennedydamm 55 / Roßstrasse
40476 Düsseldorf / DE
Former [2012/08]Ihle, Kornelia
Viering, Jentschura & Partner
Kennedydamm 55/Rossstr.
40476 Düsseldorf / DE
Former [2010/51]Ihle, Kornelia
Viering, Jentschura & Partner Grillparzerstr. 14
81675 München / DE
Application number, filing date09714213.724.02.2009
[2010/51]
WO2009US34997
Priority number, dateUS20080032365P28.02.2008         Original published format: US 32365 P
[2010/51]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2009108632
Date:03.09.2009
Language:EN
[2009/36]
Type: A1 Application with search report 
No.:EP2262512
Date:22.12.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 03.09.2009 takes the place of the publication of the European patent application.
[2010/51]
Search report(s)International search report - published on:KR03.09.2009
ClassificationIPC:A61K35/12, A61P25/28, A61K47/26, A61K35/28
[2010/51]
CPC:
A61K35/28 (EP,US); A61K35/407 (EP,US); A61K35/44 (EP,US);
A61K47/26 (EP,US); A61K9/0019 (EP,US); A61P21/00 (EP);
A61P25/00 (EP); A61P25/08 (EP); A61P25/14 (EP);
A61P25/16 (EP); A61P25/28 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/51]
TitleGerman:ZUSAMMENSETZUNGEN UND VERFAHREN ZUR VERWENDUNG VON STROMAZELLEN ZUR VERSTÄRKUNG DER BEHANDLUNG VON SCHÄDEN DES ZENTRALEN NERVENSYSTEMS[2010/51]
English:COMPOSITIONS AND METHODS FOR USING STROMAL CELLS TO ENHANCE TREATMENT OF CENTRAL NERVOUS SYSTEM INJURIES[2010/51]
French:COMPOSITIONS ET PROCÉDÉS D UTILISATION DE CELLULES STROMALES POUR AMÉLIORER LE TRAITEMENT DE BLESSURES AU SYSTÈME NERVEUX CENTRAL[2010/51]
Entry into regional phase27.09.2010National basic fee paid 
27.09.2010Search fee paid 
27.09.2010Designation fee(s) paid 
27.09.2010Examination fee paid 
Examination procedure27.09.2010Examination requested  [2010/51]
24.11.2010Amendment by applicant (claims and/or description)
01.09.2011Application deemed to be withdrawn, date of legal effect  [2015/11]
12.10.2011Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2015/11]
Fees paidRenewal fee
13.12.2011Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
28.02.201103   M06   Fee paid on   13.12.2011
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]  - NAKAGAMI, H. ET AL., "Adipose tissue-derived stromal cells as a novel option for regenerative cell therapy", J. ATHEROSCLER. THROMB., (2006), vol. 13, pages 77 - 81, XP002553180
 [Y]  - ERDLENBRUCH, B. ET AL., "Alkylglycerol opening of the blood-brain barrier to small and large fluorescence markers in normal and C6 glioma-bearing rats and isolated rat brain capillaries", BRITISH JOURNAL OF PHARMACOLOGY, (2003), vol. 140, pages 1201 - 1210, XP003025674
 [A]  - SAFFORD, K. M. ET AL., "Neurogenic differentiation of murine and human adipose-derived stromal cells", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, (2002), vol. 294, pages 371 - 379, XP002384763

DOI:   http://dx.doi.org/10.1016/S0006-291X(02)00469-2
 [A]  - LUO, Y. ET AL., "SDF 1 alpha/CXCR4 signaling stimulates beta-catenin transcriptional activity in rat neural progenitors", NEUROSCIENCE LETTERS, (2006), vol. 398, pages 291 - 295, XP005402754

DOI:   http://dx.doi.org/10.1016/j.neulet.2006.01.024
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.